We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$481M
AUM Growth
+$88M
Cap. Flow
+$92.1M
Cap. Flow %
19.16%
Top 10 Hldgs %
100%
Holding
12
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
CORI
Corium International, Inc.
CORI
+$70.5M
2
ELGX
Endologix Inc
ELGX
+$22M

Sector Composition

Rank Sector Weight
1 Healthcare 87.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
$156M 32.47%
4,592,047
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$89M 18.51%
5,815,940
ABMD
3
DELISTED
Abiomed Inc
ABMD
$79.2M 16.47%
3,150,000
CORI
4
DELISTED
Corium International, Inc.
CORI
$72.7M 15.11%
+9,353,304
New +$70.5M
ELGX
5
DELISTED
Endologix Inc
ELGX
$60.1M 12.49%
281,494
+164,951
+142% +$22M
ACUR
6
DELISTED
Acura Pharmaceuticals
ACUR
$10.7M 2.22%
2,056,977
-2,000
-0.1% -$12.1K
TCRT icon
7
Alaunos Therapeutics
TCRT
$4.81M
$10.3M 2.13%
18,433
MNOV icon
8
MediciNova
MNOV
$65M
$2.38M 0.49%
1,170,370
CRIS icon
9
Curis
CRIS
$7.33M
$435K 0.09%
117
ECTE
10
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$28K 0.01%
12,319
PTN
11
Palatin Technologies
PTN
$13.8M
$24K 0.01%
19
CO
12
DELISTED
Global Cord Blood Corporation
CO
-86,763
Closed -$347K

Similar funds

Essex Woodlands Management's Q2 2014 Portfolio in Review

As of Q2 2014, Essex Woodlands Management held 12 positions worth $481M, up 22% from $393M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management deployed $92.1M of net new capital in Q2 2014, opening 1 new position and adding to 1 existing holding. Its largest new stake was Corium International, Inc.: 9,353,304 shares worth $72.7M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier.

On the sell side, the largest reduction was Acura Pharmaceuticals, an estimated $12.1K trimmed.

  • Essex Woodlands Management's largest Q2 2014 buy was Corium International, Inc.: 9,353,304 shares worth $72.7M.
  • Essex Woodlands Management added most to Endologix Inc in Q2 2014, an estimated $22M increase.
  • Essex Woodlands Management's biggest Q2 2014 reduction was Acura Pharmaceuticals, cutting an estimated $12.1K.
  • Essex Woodlands Management fully exited Global Cord Blood Corporation in Q2 2014, selling an estimated $347K.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $481M portfolio in Q2 2014.
  • Essex Woodlands Management opened 1 new position and closed 1 in Q2 2014.
  • Essex Woodlands Management's portfolio value rose 22% quarter-over-quarter to $481M.

Based on Essex Woodlands Management's 13F filing for Q2 2014, filed 13 Aug 2014.